TK

Thandaythabhani Kavitha

Active Director Director DIN 10235520
DIN 10235520 First appointment Jul 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Thandaythabhani Kavitha

Data last updated:

Thandaythabhani Kavitha is a Director at Kalanrix Pharma Private Limited (since 2023). Kalanrix Pharma Private Limited reported revenue of ₹27.7 Lakh (FY 2025).

DIN 10235520
Primary Designation Director
First Appointment 11 Jul 2023
Oldest Company Age 3 yrs
Largest company Kalanrix Pharma Private Limited · ₹27.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kalanrix Pharma Private Limited U46497TN2023PTC161844
Director11 Jul 20232023₹27.7 Lakh (FY 2025)Active

Board colleagues of Thandaythabhani Kavitha

NameDINCompanyDesignation
Asokan Periyasamy07472628Kalanrix Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kalanrix Pharma Private Limited
Premium access

Shareholding and investment profile for Thandaythabhani Kavitha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thandaythabhani Kavitha

Thandaythabhani Kavitha currently holds 1 directorship: Kalanrix Pharma Private Limited (Director, since 11 Jul 2023, revenue ₹27.7 Lakh (FY 2025)).

Thandaythabhani Kavitha was first appointed on 11 Jul 2023 as Director at Kalanrix Pharma Private Limited.

The current boards of Thandaythabhani Kavitha's companies include Asokan Periyasamy (Kalanrix Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available